ginsenoside rh2 has been researched along with Inflammation in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (60.00) | 24.3611 |
2020's | 2 (40.00) | 2.80 |
Authors | Studies |
---|---|
Hu, Y; Lang, Z; Tao, Q; Wang, H; Yu, S; Yu, Z; Zhang, J; Zheng, J; Zheng, L | 1 |
Ahn, S; Castro-Aceituno, V; Jiménez-Pérez, ZE; Jung, SK; Kim, YJ; Mathiyalagan, R; Simu, SY; Subramaniyam, S; Wang, C; Yang, DC | 1 |
Chen, X; Liu, S; Lv, X; Xu, T; Zhang, J | 1 |
Choi, YH; Li, LC; Lin, ZH; Piao, HM; Yan, GH; Zheng, MY | 1 |
Bi, WY; Fu, BD; Li, HP; Lv, S; Qin, QQ; Shen, HQ; Song, Z; Wei, Q; Wei, XB; Wu, SC; Yi, PF; Zhang, C | 1 |
5 other study(ies) available for ginsenoside rh2 and Inflammation
Article | Year |
---|---|
Ginsenoside Rh2 promotes hepatic stellate cell ferroptosis and inactivation via regulation of IRF1-inhibited SLC7A11.
Topics: Amino Acid Transport System y+; Ferroptosis; Fibrosis; Hepatic Stellate Cells; Humans; Inflammation; Interferon Regulatory Factor-1; Iron; Liver Cirrhosis | 2023 |
Preparation of Polyethylene Glycol-Ginsenoside Rh1 and Rh2 Conjugates and Their Efficacy against Lung Cancer and Inflammation.
Topics: A549 Cells; Animals; Antineoplastic Agents, Phytogenic; Carcinoma, Non-Small-Cell Lung; Drug Delivery Systems; Ginsenosides; Humans; Inflammation; Lung Neoplasms; Macrophages; Mice; Polyethylene Glycols; RAW 264.7 Cells | 2019 |
Ginsenoside Rh2 alleviates ulcerative colitis by regulating the STAT3/miR-214 signaling pathway.
Topics: Animals; Anti-Inflammatory Agents; Cell Line; Colitis, Ulcerative; Cytokines; Dextran Sulfate; Disease Models, Animal; Ginsenosides; Humans; Inflammation; Male; Mice, Inbred C57BL; MicroRNAs; Signal Transduction; STAT3 Transcription Factor; Sulfasalazine | 2021 |
Ginsenoside Rh2 attenuates allergic airway inflammation by modulating nuclear factor-κB activation in a murine model of asthma.
Topics: Animals; Anti-Asthmatic Agents; Anti-Inflammatory Agents; Asthma; Female; Ginsenosides; Immunoglobulin E; Inflammation; Interleukin-13; Interleukin-4; Interleukin-5; Lung; Mice; Mice, Inbred BALB C; NF-kappa B; Ovalbumin | 2015 |
Sulfated derivative of 20(S)-ginsenoside Rh2 inhibits inflammatory cytokines through MAPKs and NF-kappa B pathways in LPS-induced RAW264.7 macrophages.
Topics: Animals; Anti-Inflammatory Agents; Cells, Cultured; Ginsenosides; Inflammation; Interleukin-10; Interleukin-1beta; Interleukin-6; JNK Mitogen-Activated Protein Kinases; Lipopolysaccharides; Macrophages; Mice; Mitogen-Activated Protein Kinases; NF-kappa B; p38 Mitogen-Activated Protein Kinases; Phosphorylation; RNA, Messenger; Sulfates; Transcription Factor RelA; Tumor Necrosis Factor-alpha | 2012 |